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Abstract Even though the mammalian heart has been
investigated for many years, there are still uncertainties in
the fields of cardiac cell biology and regeneration with re-
gard to exact fractions of cardiomyocytes (CMs) at different
developmental stages, their plasticity after cardiac lesion
and also their basal turnover rate. A main shortcoming is the
accurate identification of CM and the demonstration of CM
division. Therefore, an in vivo model taking advantage of a
live reporter-based identification of CM nuclei and their cell
cycle status is needed. In this technical report, we describe
the generation and characterization of embryonic stem cells
and transgenic mice expressing a fusion protein of human
histone 2B and the red fluorescence protein mCherry under
control of the CM specific aMHC promoter. This fluores-
cence label allows unequivocal identification and quanti-
tation of CM nuclei and nuclearity in isolated cells and
native tissue slices. In ventricles of adults, we determined a
fraction of\20 % CMs and binucleation of 77–90 %, while
in atria a CM fraction of 30 % and a binucleation index of
14 % were found. We combined this transgenic system with
the CAG-eGFP-anillin transgene, which identifies cell di-
vision and established a novel screening assay for cell cy-
cle-modifying substances in isolated, postnatal CMs. Our
transgenic live reporter-based system enables reliable
identification of CM nuclei and determination of CM frac-
tions and nuclearity in heart tissue. In combination with
CAG-eGFP-anillin-mice, the cell cycle status of CMs can
be monitored in detail enabling screening for proliferation-
inducing substances in vitro and in vivo.
Keywords Cardiac myocyte  Cell cycle  Genetically
altered mice  Proliferation  miRNA
Introduction
The mammalian heart is composed of different cell types
such as endothelial cells, fibroblasts, smooth muscle cells,
and cardiomyocytes (CMs). The latter provide the con-
tractile properties of the heart muscle and CM loss in
pathologies, such as myocardial infarction or cardiomy-
opathy, leads to functional impairment and eventually heart
failure [16]. While there is mutual consent that CMs make
up the majority of the heart mass [20], there is a discrep-
ancy regarding the fraction of CMs in the mammalian heart
which is estimated to be composed of 15–35 % CMs [25,
37, 42], as addressed by histology but not specific cell
markers [3]. A recent report, using flow cytometry, claims
that mouse hearts exceptionally consist of 55 % of CMs
[2]. Also identifying CM nuclei is challenging in cardiac
sections in which CM cytoplasm is identified either by
immunohistological staining for structural proteins or by
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transgenic CM-specific overexpression of fluorescence
proteins. In those sections, non-CM nuclei in close prox-
imity to CM cytoplasm cannot be distinguished from CM
nuclei leading to false positives [1].
The majority of CMs are polyploid, caused either by an
increase in nuclearity with *90 % binuclear ventricular
CMs in mouse [37, 43] and rat [21], and 25.5–61.9 % in
humans [8, 29] or by increased nuclear ploidy up to 8N in
humans [24] and 16N in mice [43]. Polyploid cells are
thought to be unable to undergo cell division, but are still
able to enter the cell cycle and to perform DNA synthesis
resulting in CMs with further increased ploidy [14, 23].
Heart regeneration is commonly analyzed with proliferation
markers localized in the nucleus, such as PCNA, Ki-67, or
pHH3 or Thymidine analogs such as BrdU or 3H-Thymi-
dine. The results of these studies depend strongly on the
unequivocal identification of CM nuclei, which is error-
prone without the use of a specific nuclear CM marker [1].
This could be one of the major reasons for the discrepancies
concerning the estimates of annual turnover rates of adult
mouse CMs, ranging from 0.76 % [33] up to 80 % [17] and
the regeneration potential after experimental lesions, esti-
mated from 0 % [15, 44] up to 15.3 % [18]. Using a new
in vivo proliferation marker, the eGFP-anillin system, we
recently showed that adult CMs undergo endoreduplication
(DNA replication without karyokinesis or cytokinesis)
rather than cell division after cardiac lesion in mice [15].
Two challenges arise from the above-mentioned dis-
crepancies, firstly the unambiguous identification of CM
nuclei and secondly the confirmation of CM division and
not mere cell cycle activity.
Here, we report the generation of a reporter system that
directly visualizes CM nuclei in vitro and in vivo, by fusing
the red fluorescence protein mCherry (mCh) to human
histone 2B (H2B) and expressing it in CMs by use of the
aMHC (Myh6) promoter. We demonstrate that this fusion
protein accurately labels CM nuclei and allows the deter-
mination of CM portions and nuclearity during postnatal
development of the mouse heart and after cardiac injury.
We further combine aMHC-H2B-mCh mice with the
CAG-eGFP-anillin mouse line for unambiguous visual-
ization of cell cycle progression and division of postnatal
CMs and for establishing a screening assay for cell cycle-
modifying substances.
Methods
Generation of the aMHC-hH2BmCh-IRES-PuroR
vector
The pIRES2-eGFP vector (CLONTECH Laboratories,
Inc.) was digested with AseI and NheI, blunt-ended and
religated. Thereby the CMV IE promoter was excised.
EGFP was replaced by the PuromycinR (PuroR) cassette
(HindIII-ClaI fragment) of the Cre-Pac vector. The re-
sulting vector (pIRES2-PuroR) was opened with BglII,
blunt-ended and subsequently digested with XhoI. The
mouse aMHC promoter [5.5 kb BamHI(blunt)-SalI frag-
ment] of the aMHC-pBK plasmid (kindly provided by J.
Robbins, University of Cincinnati, Cincinnati, OH) was
inserted into the opened pIRES2-PuroR-vector (paMHC-
IRES2-PuroR).
The pCAG-hH2B-mCh-IRES-PuroR expression vector
was a gift from Heiko Lickert, Helmholtz Zentrum
Mu¨nchen. The vector was digested with NotI, blunt-ended,
and cut with AccIII. The excised H2BmCh-IRES-Puro
fragment was ligated into the EcoICRI-AccIII opened
paMHC-IRES-PuroR vector, thereby replacing the IRES2-
sequence and part of the PuroR cDNA of the vector. The
resulting vector aMHC-hH2B-mCh-IRES-PuroR (aMHC-
H2B-mCh) was verified by restriction analysis and
sequencing.
Generation and cultivation of transgenic ESC clones
G4 hybrid ESCs [12] were cultured in Knockout-Dulbec-
co’s modified Eagle’s medium (DMEM), high-glucose,
supplemented with 15 % v/v fetal calf serum (FCS),
0.1 mM nonessential amino acids, 2 mg/ml L-Glutamine,
50 lg/ml each penicillin and streptomycin, 0.1 mM b-
mercaptoethanol, and 500 U/ml Leucemia inhibitory factor
(LIF). The ESCs were kept on irradiated neomycin-resis-
tant mouse embryo fibroblasts (Millipore).
For generation of transgenic ESCs 5 9 106 cells were
mixed with 30 lg of linearized plasmid DNA in PBS and
electroporated at 250 V and 500 lF, 1 pulse, using a Bio-
Rad Gene Pulser. The cells were plated on two 100-mm
plates. Selection for neomycin-resistant cells started 2 days
after electroporation by adding 165 lg/ml G418 to the
medium. Resistant colonies were picked onto mouse em-
bryonic fibroblast-coated 24-well plates, propagated and
analyzed for mCh expression.
Differentiation of transgenic ESCs and purification
of CMs
ESC differentiation was performed using mass culture. In
brief, 2.0 9 106 ESCs were suspended in 10 ml differen-
tiation medium (Iscove’s Modified Dulbecco’s Medium
(IMDM), supplemented with 20 % FCS, 0.1 mM
nonessential amino acids, 50 lg/ml each penicillin and
streptomycin, 0.1 mM b-mercaptoethanol in the absence of
LIF and cultivated on a horizontal shaker at 70–80 rpm,
37 C, and 5 %CO2 for 2 days. Half of the EBs were further
cultivated in a CELLSPIN 500 (INTEGRA biosciences)
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spinner flask. To select for CMs, puromycin treatment
(0.5–1.5 lg/ml depending on the resistance of particular
clone) was started on day 10 of differentiation in suspension
culture. For isolation of CMs on d11 and d13, the EBs were
dissociated with 0.125 % Trypsin/EDTA for 5 min. Treat-
ment was stopped with differentiation medium and the cells
were centrifuged (210 g, 5 min). *105 cells were plated on
coverslips, pre-treated with 10 lg/ml fibronectin in 24-well
tissue plates, cultured for 48 h in differentiation medium,
and for further purification of CMs puromycin was added.
Cells were fixed with 4 % paraformaldehyde (PFA) at room
temperature (RT) for 30 min.
Copy number determination by qPCR
The copy number of the H2B-mCh transgene was deter-
mined in different ESC clones applying a TaqMan-based
qPCR assay as described by the manufacturer (Applied
Biosystems). For the transgene detection, a Car-
boxyfluorescein (FAM)-coupled mCh probe (Applied
Biosytems) was used and as genomic reference a VIC-
coupled probe for the Transferrin receptor was chosen.
Both probes were analyzed in triplicates for each gDNA




All animal experiments were performed in accordance with
the guidelines from Directive 2010/63/EU of the European
Parliament on the protection of animals used for scientific
purposes and were approved by the Animal Care Com-
mittees (8.87-50.10.31.08.199 and 8.87-50.10.37.09.238).
Transgenic ESC clones were screened for a proper kary-
otype (40 chromosomes) and aggregated with diploid
morula stage CD1 embryos as described previously [26].
Ventricular cryolesions were generated in 10-week-old
mice with 3.5-mm liquid-nitrogen-cooled copper probes as
described earlier [31]. Briefly, mice were anesthetized with
4 Vol% Isoflurane, 0.6 l/min O2, 0.4 l/min N2O, intubated
and ventilated. The concentration of Isoflurane was re-
duced to 1–2 Vol%. The heart was exposed by thoracoto-
my. For local anesthesia, 0.1 ml of a 0.5 % Bupivacaine
solution was injected into the intercostal musculature.
Cryolesions at the anterolateral left ventricular wall were
generated using liquid-nitrogen-cooled copper probes
3.5 mm in diameter. For ligation the left anterior de-
scending (LAD) coronary artery was occluded directly
distal of the left atrial auricle. For peri-operative analgesia,
20 mg/kg s.c Metamizol was used and 5 mg/kg s.c.
Carprofen was used for analgesia post operation for 5 days.
Neonatal mice were euthanized by decapitation and adult
mice by cervical dislocation.
Left ventricular catheterization and hemodynamics
Left ventricular catheterization was performed on
15-week-old H2B-mCh and CD1 wt mice by a blinded
investigator (for detail see [11]). Briefly, a 1.4 F Millar
Aria1 catheter (Millar Instruments Inc., Houston, USA)
was inserted under general anesthesia via the right carotid
artery into the left ventricle, and pressure-volume (PV)-
loops were recorded online. For analysis, Millar PVAN
software was used. After the experiment, mice were sac-
rificed and hearts were harvested for histological analysis.
Dissociation of postnatal mouse hearts and miRNA
transfection
Mice were sacrificed on d2/d3/d7 after birth; the hearts were
prepared and analyzed for H2B-mCh expression by using a
macroscope (AxioZoom.V16, Zeiss). Atria and ventricles
of the transgenic hearts were separated and dissociated us-
ing the Neonatal heart dissociation kit (Miltenyi Biotec)
without using the gentle MACS Dissociator. The heart tis-
sue was dissected by slowly pipetting every 15 min. 7500
cells were seeded per well on a 0.001 % fibronectin-coated
384-well l-clear microtiter plate (Greiner). Cells were in-
cubated in differentiation medium (see above) at 37 C and
5 % CO2. For analysis of the binucleation index, cells were
fixated after overnight adhesion to the dish.
In order to transfect postnatal CMs, ventricles of aMHC-
H2B-mCh/CAG-eGFP-anillin double transgenic hearts
were dissociated as described above. 5 ll of 500 nM Stock
solutions of hsa-miR-199a-3p or miR mimic, Negative
control #1 (Ambion, Life Technologies) were incubated
with 0.2 ll Lipofectamine RNAi Max (Invitrogen) in
14.8 ll OPTI-MEM on 0.001 % fibronectin-coated
384-well l-clear microtiter plates (Greiner) for 20 min at
RT. Afterward, 7500 dissociated cells were added in a vol-
ume of 60 ll differentiation medium. Medium was changed
after 48 h and the cells were further incubated for 24 h.
Harvesting of mouse hearts
Heparinized adult mice were sacrificed by cervical dislo-
cation and the hearts were harvested. After cannulation of
the ascending aorta, the hearts were perfused with PBS,
followed by perfusion with 4 % PFA, and further fixation
overnight. Embryonic and postnatal hearts were excised
and immersion fixated in 4 % PFA. Hearts were dehy-
drated in 20 % sucrose solution and mounted in O.C.T.
compound.
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Langendorff dissociation
Ventricular myocytes from adult mice were enzymatically
isolated by Langendorff perfusion as previously described
[39], with minor variations. Briefly, animals were killed by
cervical dislocation. The heart was dissected and perfused
using oxygenated Ca2?-free Tyrode solution (135 mM
NaCl, 4 mM KCl, 1 mM MgCl2, 2.5 mM HEPES, 5 mM
Glucose, pH 7.4) with 25 mM 2,3-Butanedione monoxime
(BDM) for 5 min. The enzymatic digestion with 1 mg/ml
(activity 0.199 U/mg) Collagenase B and 0.033 mg/ml
Trypsin was performed in oxygenated Tyrode solution
with 25 mM BDM and 50 lM CaCl2 for 8–12 min and
after manually dissecting the tissue the reaction was stop-
ped in stopping solution (oxygenated Tyrode solution with
25 mM BDM, 50 lM CaCl2 and 5 % FCS). The cell sus-
pension was filtered through a 100-lm Cell strainer and
centrifuged (700 rpm, 1 min). Isolated cells were plated on
8 lg/ml laminin-coated coverslips in 24-well plates in
differentiation medium (see above) at 37 C, 5 % CO2 for
5 h and fixated with 4 % PFA solution afterward.
Histology and immunofluorescence stainings
Following PFA fixation, all tissues and EBs were incubated
in 20 % sucrose in PBS prior to cryopreservation in Tissue
Tek O.C.T. compound (Sakura Finetek Europe B.V.).
Sectioning of 10 lm/50 lm cryoslices was performed with
a cryotome CM 3050S (Leica).
Fixated cells and tissue slices were stained for the fol-
lowing differentiation and proliferation markers (in 0.2 %
Triton X in PBS, supplemented with 5 % donkey serum; 2 h
at RT): a-actinin (1:400, Sigma–Aldrich A7811), cTropT
(1:50, DSHB Hybridoma Product RV-C2), PCM-1 (1:200,
Cell Signaling G2000), and Aurora B kinase (1:400, Sigma-
Aldrich A5102). For the PCM-1 staining a short antigen-
retrieval with 10 mM sodium citrate, pH 6.0, was performed
in a KOS Microwave (Milestone, program: 4 min 70 C,
3 min 85 C, 4 min 90 C, 5 min 93 C), which allowed
conservation of the H2B-mCh fluorescence. Primary anti-
bodies were visualized by secondary antibodies conjugated to
Cy5 (1:400, Jackson ImmunoResearch) diluted in 1 lg/ml
Hoechst 33342 (nuclei staining) at RT for 1 h. Fluorescein
Griffonia Simplificiosa Lectine (GSL, Vector Laboratories)
was diluted 1:100 and stained at RT for 1 h. Immunostainings
were documented with an inverted fluorescence microscope
(Axiovert 200; Carl Zeiss MicroImaging, Inc.) equipped with
a slider module (ApoTome; Carl Zeiss MicroImaging, Inc.).
Sirius red, hematoxylin, and eosin stainings were performed
using standard histology protocols. Pictures were acquired
with an AxioStar Plus microscope (Zeiss).
For quantification of CM nuclei fractions in different
regions of the heart, 10-lm thick transversal cryo-sections
were analyzed (zone 1: section at atria level, zone 2: sec-
tion through the middle of the ventricle, determined by
length measurement of a macroscopic picture of each heart,
zone 3: section in *200 lm distance from the apex). The
following 259 pictures of cross-sectioned CMs were ana-
lyzed per mouse (n = 3 per time point) and time points
(P3, P7, 9 W): zone 1: left A atrium, LV left ventricle
compact zone, LV trabecular zone, RV right ventricle
compact zone, RV trabecular zone, zone 2: LV compact
zone, LV trabecular zone, RV compact zone, RV trabecular
zone, layer 3: LV compact zone, LV trabecular zone.
Determination of binuclearity and fractions of CM
nuclei in thick slices
PFA-fixated, cryopreserved hearts were sliced into 50-lm
thick sections with a cryotome CM 3050S (Leica) and
treated with RNAse A (20 lg/ml) in wash buffer (0.5 M
NaCl, 0.1 M Tris pH 7.5, 50 mM EDTA) for 1 h at 37 C.
Slices were incubated with 1 lM TO-PRO3 iodide (642/
661) (Molecular Probes) and Fluorescein wheat germ ag-
glutinine (WGA) (1:100, Vector Laboratories) at 4 C
overnight. Image stacks were acquired with an inverted
confocal laser scanning microscope (Nikon Eclipse Ti)
equipped with a 940/1.15 NA water-dipping objective
(ApoLWD 409 WI SDIC N2). Stacks with a z-step width
of 0.5 lm were recorded. Excitation wavelengths for
WGA, H2B-mCh, and TO-PRO 3 were 488, 543, and
642 nm, respectively. Binucleation was determined in
z-stacks manually by scrolling through the different layers
of the stack. Only cells that lay completely within the
z-stack (WGA staining visible in every dimension) were
quantified.
The number of CM nuclei (H2B-mCh?) and all nuclei
(TO-PRO3?) was determined in 3D-reconstructions using
the automatic 3D analysis module of NIS Elements. The
result was verified by manually correcting for doublets,
which were nuclei in very close proximity to each other,
that were not correctly separated by the software. Virtual
longitudinal and cross sections (0.5 lm) were generated
using NIS Elements. Per thick slice C3 longitudinal sec-
tions with a distance of 10 lm to each other were manually
analyzed for H2B-mCh signals and TO-PRO3 signals. In
virtual cross sections, the distance between the analyzed
sections (n C 4 per thick slice) was 40 lm.
Nuclei isolation and flow cytometry
Nuclei isolation experiments were performed as reported
earlier [5]. In brief, frozen adult H2B-mCh hearts were cut
into pieces manually and put in ice cold lysis buffer (in
mM: 350 Sucrose; 5 CaCl2; 5 C4H6MgO4–4H2O; 2.0
EDTA; 0.5 EGTA; 10 Tris–HCl (pH 8.0); 1 DTT). The
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heart pieces were homogenized with a T-25 Ultra-Turrax
probe homogenizer (IKA) at 24 k rpm for 10 s and then
using a glass dounce to further homogenize the tissue and
to free the nuclei. The crude lysate was passed through a
100- and 70-lm nylon mesh cell strainer (BD Biosciences),
consecutively, and then centrifuged at 700 g for 10 min in
(4 C). The nuclei pellet was re-suspended in sucrose
buffer containing (in mM) the following: 2100 sucrose; 5
C4H6MgO4–4H2O; 1 DTT; 10 Tris–HCl (pH 8.0). By using
gradient centrifugation, the sample was centrifuged at
13,000 g for 60 min in 4 C. The nuclei pellet was re-
suspended in nuclei storage buffer containing (in mM) the
following: 440 sucrose; 70 KCl; 10 MgCl2; 10 Tris–HCl
(pH 7.2); 1.5 spermine. Nuclei were stained with rabbit
anti-mouse PCM-1 (Cell Signaling Tech.) overnight in
4 C. Primary antibody was visualized with secondary
antibody conjugated to FITC (Jackson ImmunoResearch)
and DNA was stained with DAPI. Cytometric acquisition
was performed on Aria III (BD Biosciences) using the
70-lm nozzle. Positive gates were set according to un-
stained controls, FMO controls, and single staining con-
trols. Analysis was done using FlowJoTM Version V10.
Statistical analysis
Data are depicted as mean ± SEM. Statistical significance
was determined by Student’s unpaired t test or 1way
ANOVA with Bonferroni’s multiple comparison test.
p\ 0.05 was considered statistically significant.
Results
Characterization of aMHC-hH2B-mCh-IRES-
PuroR transgenic ESC clones
To establish a system that allows unequivocal identification
of CM nuclei in vitro and in vivo, we cloned a fusion
cDNA consisting of human histone 2B (H2B) and mCh
behind the cardiac-specific a-Myosin-heavy-chain (aMHC,
Myh6) promoter (Fig. 1a). The construct also contained an
internal ribosomal entry site (IRES) followed by a Pur-
omycin resistance cassette for the enrichment of CMs. We
used a fusion protein with H2B for two main reasons: First,
for determination of the cell cycle activity in CMs nuclear
markers such as BrdU or Ki-67 are used most commonly,
rendering the clear identification of CM nuclei of crucial
importance [1]. Second, after dissolving of the nuclear
membrane in M-phase, transgenic systems using a nuclear
localization signal encounter a translocation of the
fluorescence protein to the cytoplasm, which is hard to
detect for cell tracking image analysis algorithms [27].
Additionally, H2B fusion proteins have a very long half-
life [40], therefore maintaining the nuclear signal during
potentially fluctuating activity of the aMHC promoter.
For generation of transgenic mice and in vitro analysis
of H2B-mCh expression in CMs, we generated stably
transfected mouse embryonic stem cell (mESC) lines and
differentiated these into embryonic bodies (EBs). The ex-
pression of the reporter construct became visible around
day 8 of differentiation (day 8). This correlated with the
appearance of the first spontaneous beating cell clusters in
the EBs and H2B-mCh expression was restricted to these
areas (Fig. 1b, Suppl. video 1). Cryoslices of fixated EBs at
day 10 revealed an exclusive expression of the H2B-mCh
protein in the nuclei of a-actinin? CMs (Fig. 1c, d). On day
10 puromycin treatment was started for 3 days to enrich for
ESC-derived CMs. During puromycin treatment, EBs were
dissociated and the cells replated (Fig. 1e), followed by
quantification of H2B-mCh?/a-actinin? CMs (Fig. 1f),
which revealed a *16-fold enrichment of CMs (Fig. 1g).
The overlap of H2B-mCh expression and a-actinin staining
was 96 ± 1.5 %, revealing high specificity of the trans-
gene. In summary, the aMHC-H2B-mCh system can
identify CM nuclei in vitro and CMs derived from the
transgenic ESCs are viable and can be enriched by pur-
omycin treatment.
H2B-mCh specifically marks CM nuclei
in transgenic hearts
From a characterized aMHC-H2B-mCh ESC clone with
only one transgene integration, we generated a transgenic
mouse line by aggregation with diploid embryos from
wildtype CD1 mice. The chimeric mice provided germ-line
transmission and the transgenic progeny was viable, fertile,
and had a normal lifespan.
Macroscopically, H2B-mCh adult hearts displayed mCh
fluorescence in ventricles and atria (Fig. 2a), and higher
magnification showed a restriction of the H2B-mCh ex-
pression to nuclei (Fig. 2a, right picture). Cryoslices of
these hearts revealed that the expression of the fusion
protein was specific for all CM nuclei (Fig. 2b), which
were identified by a-actinin staining (Fig. 2c).
As a definitive proof that H2B-mCh exclusively marks
all CMs, we performed Langendorff dissociation of
aMHC-H2B-mCh hearts (n = 6) to verify the specificity
and the penetrance of our reporter system. All CMs with
rod-shaped morphology and positive for a-actinin ex-
pressed H2B-mCh in their nuclei (Fig. 2d; n = 1610)
proving complete penetrance, while nuclei from other cells
were negative for H2B-mCh (Fig. 2d, arrows). The speci-
ficity to heart tissue was further demonstrated by analyzing
sections from skeletal muscles such as M. tibialis anterior
and diaphragm, which did not display any H2B-mCh ex-
pression (Fig. 2e).
Basic Res Cardiol (2015) 110:33 Page 5 of 18 33
123
We further investigated the specificity of the H2B-mCh
expression pattern by staining with GSL to exclude ex-
pression in endothelial cells (Fig. 2f). There were several
nuclei, which were covered by cross-striations and
therefore seemingly belonged to CMs, but were clearly
H2B-mCh negative (Fig. 2f, arrows) and vice versa
(Fig. 2f, arrowheads). This underlines the difficulty to
unequivocally identify CM nuclei on tissue sections.
Recent studies on cardiac turnover relied on the correct
identification of CM nuclei by antibody staining for
specific markers such as Troponin I and T [4] and PCM-1
[6], followed by flow cytometry analysis. To test, if our
system can be used to identify CM nuclei out of total nuclei
from hearts, we isolated cardiac nuclei from adult H2B-
mCh mice and analyzed these by flow cytometry.
H2B-mCh? nuclei were easily detectable by flow cy-
tometry and contributed to 25.0 ± 4.2 % of total heart
nuclei (Fig. 2g). To assess the accuracy of the aforemen-
tioned nuclear CM markers, we exemplarily stained nuclei
from H2B-mCh? hearts for PCM-1. Flow cytometric
analysis of the stained nuclei revealed a distinct CM-
population for H2B-mCh, while the PCM-1 staining dis-
played a broad spreading (Fig. 2h); the correlation between
the two markers was 90 %, (Fig. 2h). Staining for PCM-1
on tissue sections of adult mouse hearts also revealed a
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bFig. 1 Identification of CM nuclei in vitro. a Expression construct
used for the generation of aMHC-H2B-mCh transgenic mouse ESCs.
b H2B-mCh expression in beating areas of EBs at d14 of differen-
tiation. Scale bar 200 lm. c Section of an H2B-mCh? EB indicates
specific expression of the fusion protein in CMs, identified by a-
actinin staining. Scale bar 50 lm. d Close-up of a CM-rich region of
an H2B-mCh? EB. CMs were identified by a-actinin staining. Scale
bar 20 lm. e Protocol for differentiation of ESCs and selection for
CMs. f Selection for CMs in H2B-mCh transgenic EBs by puromycin
treatment. Left picture shows dissociated EBs without selection and
right picture with puromycin treatment for 3 days. H2B-mCh? CMs
were verified by a-actinin staining. Scale bar 100 lm. g Quantifica-
tion of the selection for CMs in aMHC-H2B-mCh transgenic EBs
(d13) treated with puromycin for 3 days (n = 3)
cFig. 2 Specificity of H2B-mCh expression in CM nuclei of adult
transgenic mice. a Macroscopic picture of an aMHC-H2B-mCh heart
at adult stage. Scale bars 500 lm. Right picture shows a close-up of
the ventricular region. Scale bar 100 lm. b Transversal section of an
aMHC-H2B-mCh heart reveals expression of the fusion protein in
nuclei. Scale bar 500 lm. c Section of an aMHC-H2B-mCh heart
stained for a-actinin to prove expression of the fusion protein in CMs.
Scale bar 20 lm. d Langendorff dissociation demonstrates expression
of H2B-mCh in all CMs. Scale bar 50 lm. e H2B-mCh is not
expressed in nuclei of skeletal muscle cells of H2B-mCh mice. Scale
bar 20 lm. f aMHC-H2B-mCh? heart section stained with GSL to
identify endothelial cells. CMs were identified by cross striation in
DIC. Arrows mark nuclei that could be misinterpreted as CM nuclei,
arrowheads mark cells that would not have been identified as CM
nuclei without the transgene. Scale bar 20 lm. g Representative flow
cytometric analysis of the percentages of H2B-mCh? and PCM-1?
single adult DAPI? nuclei. h Representative flow cytometric analysis
of the percentages of H2B-mCh in single adult DAPI? nuclei.
i Staining of PCM-1 and a-actinin in a cryo-slice of an aMHC-H2B-
mCh heart. The arrow marks a CM nucleus that is not stained by
PCM-1. Scale bar 50 lm
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not all of the CM nuclei could be clearly identified by
PCM-1 staining (Fig. 2i, arrow). To further exclude pos-
sible side effects of the transgene on CMs, we performed
morphometric analysis on Langendorff dissociated adult
CMs and excluded a hypertrophic effect of transgene
expression (Fig. 3a). Also the percentage of binucleated
adult CMs in H2B-mCh mice [89.5 ± 2 % (n = 4)] mat-
ched published numbers [21, 43]. Accordingly, 10-week-
old transgenic mice did not show any obvious differences
in heart weight (Fig. 3b) compared to their wildtype
H
A H2B-mCh B Hoechst H2B-mCh
C
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I Hoechst -actininα H2B-mCh PCM-1
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littermates. Transgene stability was monitored for 6 gen-
erations in mice from a mixed 129S6/SvEvTac 9 C57BL/
6Ncr 9 CD-1 background and for 2 generations of back-
crosses into C57BL/6 background. No changes in speci-
ficity or intensity of H2B-mCh expression were noted and
no detrimental effects on cardiac function and hemody-
namics were observed (Table 1); in addition, no fibrosis
(Fig. 3c) could be detected.
Next, we analyzed transgene expression during embry-
onic development and neonatal stages. At E12.5, E15.5,
and E18.5, the expression of H2B-mCh was limited mainly
to the atria (Fig. 3d), probably due to the restricted activity
of the aMHC promoter [22]. Although there was some
expression in the trabecular zone of the left and right
ventricles (Fig. 3e), the H2B-mCh signals were only de-
tectable in a subpopulation of CMs and expression was
significantly weaker compared to atrial CMs.
In neonatal mice, transgene expression was found to be
already increased in ventricular CMs compared to late
embryonic hearts (P0 in Fig. 4a) and on P3 solid expres-
sion of the H2B-mCh protein was detectable in ventricular
and atrial CMs (P3 in Fig. 4a), as demonstrated by high
overlap of a-actinin staining and H2B-mCh expression
after dissociation (Fig. 4b).
After demonstrating the high specificity and complete
penetrance of our transgene for CMs, we applied our sys-
tem to several open biological questions concerning CM
fractions, ploidy, and cell cycle status.
Determination of CM nuclei fractions at postnatal
stages
One focus of our study was the precise determination of the
CM nuclei fraction in different areas of the heart and at
different developmental time points after birth, which is of
particular relevance for studying cardiac regeneration. For
our analysis, we have chosen an early postnatal time point
at which the heart still has proliferative capacity (P3), a
later postnatal time point at which the heart is just losing its
potential to regenerate (P7) and adult age (9 weeks) when
the heart is terminally differentiated. Figure 4a displays
epifluorescence pictures of transgenic hearts at P0, P3, P7,
and at adult stage [9 weeks (9 W)]. While the expression
level of H2B-mCh increased in the ventricle during post-
natal development, it did not change in atria (Fig. 4a,
close-ups).
For quantification of CM nuclei fractions, we analyzed
heart sections for H2B-mCh? nuclei and total cardiac nu-
clei. We assumed that due to the occurrence of binucleated
CMs, there would be a difference between quantification of
CM nuclei based on either transverse or cross sections. In a
cross section, only one of the two nuclei of a binucleated
CM can be visible, while in longitudinal sections the
chance to detect both nuclei is limited by section thickness.
Therefore, both methods could be error-prone and either
underestimate or overestimate the number of CMs. To
determine the difference of counting transverse or cross




















































Fig. 3 Assessment of cardiac morphology in H2B-mCh mice and
H2B-mCh expression during embryonic development. a Exclusion of
hypertrophic effects of the transgene in Langendorff dissociated adult
CMs. N = 3 animals per group; n[ 110 CMs per group. b Compar-
ison of heart weight to tibia length between 10-week-old male
aMHC-H2B-mCh transgenic and wt littermates (n = 3). c Sections of
H2B-mCh and wt hearts stained with Picrosirius red for collagen.
Scale bar 100 lm. dMacroscopic pictures of E12.5, E15.5, and E18.5
H2B-mCh transgenic hearts illustrate the expression of the fusion
protein in atrial and some ventricular CM nuclei. Scale bar 500 lm.
e Section of an E15.5 H2B-mCh heart (left picture) displays strong
expression in atrial CM nuclei (right upper picture) and weak
expression in some ventricular trabecular CMs (right lower picture).
Scale bars 200 lm (overview), 50 lm (close-ups)
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fraction of CM nuclei in volume 3D-reconstitutions of
Z-stacks of thick (50 lm) slices from adult aMHC-H2B-
mCh hearts without taking into account the degree of
binucleation. Nuclei were stained with TO-PRO3 iodide,
cell borders were visualized by WGA staining and CM
nuclei were identified by nuclear H2B-mCh fluorescence
(Fig. 4c). The effect of quantification of longitudinal or
cross cardiac sections was determined by generating virtual
sections from the 3D volume view (Fig. 4c). Interestingly,
both methods of quantification gave very similar results
compared to the fraction of CM nuclei obtained by
analyzing the 3D reconstitution (Fig. 4d).
To assess potential regional differences in the fraction of
CM nuclei at each time point, which could help identifying
the most appropriate region(s) for proliferation inducing
therapeutic approaches, different zones along the longitu-
dinal axis of the heart (zone 1–3) were analyzed as depicted
in Fig. 5a; in these areas we further distinguished between
atria, left (LV) and right ventricle (RV) as well as between
the compact and trabecular zone. The CM nuclei fractions
were quantified by counting H2B-mCh? nuclei and total
number of nuclei. Quantification revealed a significant
decrease in the fraction of CM nuclei from P3 to 9 W in all
analyzed areas (Fig. 5b). At P3 a significantly higher
fraction of CM nuclei was observed in atria compared to
LV, while the CM nuclei fractions did not differ sig-
nificantly between the ventricles. At P7 the difference be-
tween CM nuclei fractions in atria and ventricles was
evened and in 9 W old hearts the fraction of CM nuclei
was *30 % in atria as well as in both ventricles (Fig. 5b).
These values were verified by flow cytometric analysis of
isolated nuclei from hearts of 10-week-old transgenic ani-
mals, in which 25.0 ± 4.2 % of nuclei turned out to be
H2B-mCh? (Fig. 2g). Regarding regional differences
within the ventricles, a significantly smaller portion of CM
nuclei was found in the trabecular zone compared to the
compact zone on P3 and P7 (Fig. 5c). However, after
compaction in adult hearts, the portion of CM nuclei was
comparable in both zones (Fig. 5c). Along the apical- to
basal heart axis, the CM nuclei fraction in the ventricles did
not differ significantly (Fig. 5d). However, there was a
slight tendency toward higher fractions of CM nuclei in
apical direction. For accurate determination of CM num-
ber, the nuclearity of the CMs had to be taken into account,
because most of the CMs in mice are binuclear [37].
Determination of CM nuclearity and CM fractions
at postnatal stages
Shortly after birth CMs, undergo cell cycle variations re-
sulting in binucleated and polyploid cells. These CMs are
thought to be terminally differentiated [35], while there is
evidence that mononucleated, diploid CMs have the po-
tential to divide after stimulation of neuregulin/ErbB4-
signaling [7] or after experimental myocardial lesion [7,
33]. To determine the actual number of CMs from the
fraction of CM nuclei and due to the potential relevance of
mononuclear CMs for regenerative approaches in the heart,
we quantified the fraction of bi- and mononucleated CMs at
different time points and in different regions of the heart.
However, the degree of binucleated CMs could not be
determined accurately with either cross sections or longi-
tudinal sections compared to 3D reconstitution (Fig. 6a).
This is due to general heart geometry and the orientation of
CMs in heart tissue, in which muscle fibers are curved and
CMs are oriented at different angles. Furthermore, in an
optimal standard cross section (5–10 lm) binucleated cells
cannot be detected, because usually only one nucleus is
sectioned at a time. In longitudinal sections, the thickness
of a standard section (5–10 lm) limits the detection of
both nuclei in binucleated CMs, if the CMs are not oriented
in parallel to the sectioning plane or nuclei of one CM are
not completely located in the same plane.
To accurately determine the ratio of mononucleated to
bi- or multinucleated CMs, we followed two different ap-
proaches. The number of nuclei per CM was counted in
enzymatically dissociated transgenic hearts at P3, P7, and
in Langendorff-dissociated hearts at 9 W. The
Table 1 Hemodynamics of
H2B-mCh hearts
Parameter WT H2B-mCh Significance (p)
Heart rate (bpm) 471.8 ± 42.6 499.7 ± 75.4 0.61
Maximum pressure (mmHg) 99.1 ± 7.9 99.6 ± 3.3 0.94
End-diastolic pressure (mmHg) 5.5 ± 5.9 4.9 ± 3.6 0.88
Stroke volume (lL) 25.5 ± 15.1 23.5 ± 7.1 0.85
Ejection fraction (%) 78.1 ± 12.4 69.4 ± 9.0 0.38
Cardiac output (lL/min) 11,787.5 ± 6295.5 11,413.9 ± 1549.7 0.93
dPdt max (mmHg/s) 9956.8 ± 1036.3 9425.9 ± 1445.6 0.63
dPdt min (mmHg/s) -10,347.2 ± 1853.1 -10,052.9 ± 1290.4 0.83
dPdt max maximum rate of pressure change in the ventricle, dPdt min minimal rate of pressure change in
the ventricle, mmHg millimeter of mercury (data are mean ± SEM, n = 3 for all)
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quantification of isolated CMs revealed a strongly in-
creased binucleation index in ventricular CMs from
11.6 ± 1.6 % at P3, to 65.5 ± 1.7 % at P7, and to
89.5 ± 2.0 % at 9 W (Fig. 6b). In atrial CMs, we deter-
mined only a slight increase in binuclearity from P3
(14.2 ± 2.2 %) to P7 (32.0 ± 1.2 %). The fraction of
multinucleated CMs exceeding binucleation was\1 % in
all cases. In parallel, confocal images of thick slices
(50 lm) of transgenic hearts at 9 W were analyzed as
Z-stacks to exclude a potential selective loss of mono- or
binucleated CMs during the Langendorff isolation proce-
dure. The slices were stained with WGA to visualize cell
borders (Fig. 6c). Only CMs that lay completely within the
z-stack (WGA staining visible in every dimension) were
analyzed.
The quantifications of Z-stacks at adult stage allowed a
separate analysis of the binucleation index in cells from the
left (77.2 ± 4.4 %; n = 5) and right ventricle
(77.8 ± 3.4 %; n = 5) and the atrium (14.4 ± 4.3 %;
n = 4) (Fig. 6b), thereby supporting the results obtained by
the analysis of the Langendorff dissociated CMs. The
fraction of mononucleated cells in the ventricles, as de-
termined by this method, was significantly higher
(p = 0.034) than with enzymatic dissociation.
By taking into account the portion of binucleated CMs,
as assessed by Z-stack analysis, enzymatic cell separation
and Langendorff dissociation, we were able to calculate the
portions of CM cells in atria and ventricles at the selected
time points (Fig. 6d). Due to the low degree of binucleation
in atria, the fraction of CMs in this compartment was
significantly higher at all analyzed stages (P3:
48.7 ± 1.4 %; P7: 36.1 ± 3.9 %; 9 W: 30.1 ± 1.6 %)
compared to ventricles at P3 (39.2 ± 2.6 %), P7
(25.8 ± 0.1 %), 9 W (16.1 ± 0.2 % dissociation) and LV
(18.1 ± 0.6 % thick slices) and RV (17.3 ± 0.6 % thick
slices), respectively.
We also explored, whether H2B-mCh expression cor-
relates to DNA content and could therefore be used as a
bFig. 4 H2B-mCh transgene expression in postnatal mouse hearts.
a Epifluorescence pictures of transgenic aMHC-H2B-mCh hearts at
different postnatal days. Scale bars 1 mm in the overview pictures,
200 lm in close-ups of atrium and ventricle. b a-Actinin staining
(white) of dissociated ventricular (left) and atrial CMs (right) of
aMHC-H2B-mCh transgenic hearts proves expression of the fusion
protein at P3. Scale bars 20 lm. c Illustration of three methods to
quantify the portion of CM nuclei in thick slices of the heart. The 3D-
analysis of H2B-mCh? nuclei in correlation to all ToPro-3? nuclei
reflects the real fraction of CM nuclei. Virtual longitudinal sec-
tions (10 lm distance, 3–4 sections per slice) or virtual cross
sections [40 lm distance, (4–5 sections per slice)] were analyzed.
Scale bars 50 lm. Colored 3D image exemplarily depicts fragmen-
tation of ToPro-3? nuclei. d Quantification of the fraction of CM


















































































Fig. 5 Determination of the percentage of CM nuclei at different
developmental stages. a Scheme illustrates the strategy used for
analyzing the CM nuclei proportion in different regions of the heart.
b Quantification of the percentage of CM nuclei at different
developmental stages. A atrium, LV left ventricle, RV right ventricle,
(n = 3). c Compact zone compared to trabecular region. d Fraction of
CMs in different zones of the heart as described in (a)
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direct readout for endoreduplication. However, neither
Hoechst staining of thick sections of the LV (Fig. 6e) nor
isolation of CM nuclei followed by nuclear staining and
flow cytometry (Fig. 6f–h) yielded a direct correlation
between H2B-mCh signal intensity and DNA content.
Easy identification of the border zone
after cryoinjury of the heart
After experimental myocardial infarction, it is challenging
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CMs in the border zone and infarcted area. This is espe-
cially true for islands of surviving CMs within the infarct.
Additionally, staining for antigens in the infarct zone is
difficult due to high background issues. We thought that
these difficulties could be addressed by the prominent
in vivo labeling of CM nuclei and therefore analyzed car-
diac sections 10 days after the injury (n = 2). The lesioned
area and the native myocardial tissue were easy to dis-
criminate macroscopically by H2B-mCh signals (Fig. 7a).
Staining of sections from lesioned transgenic hearts re-
vealed a good demarcation of the infarct area and the vi-
able myocardium with H2B-mCh? nuclei (Fig. 7b).
Specificity of the H2B-mCh signal was corroborated by
staining for a-actinin (Fig. 7c) and cardiac troponin T
(Fig. 7d).
The expression of the fusion protein further facilitates
the identification of nuclei from border zone CMs. Espe-
cially in cross sections, the reliable identification of CM
nuclei is limited without the use of a specific nuclear
marker as the CM nuclei are not always centered within the
cells (Fig. 7e, arrows). Similarly, individual CMs or small
islands of surviving CMs, which are hard to detect within
the lesioned area, are easily detectable by their H2B-mCh
nuclear signal (Fig. 7f, arrows).
In summary, the aMHC-H2B-mCh mouse line fa-
cilitates the reliable identification of CM nuclei after my-
ocardial infarction and eases the estimation of the lesion
size.
An in vitro assay for screening for proliferation-
inducing substances in CMs
A potentially very interesting strategy to regenerate lost
heart muscle is based on re-induction of proliferation in
pre-existing CMs. For this purpose preferentially neonatal
stages are used, as at this stage some proliferative activity
is still present in CMs and these cells appear to be more
amenable to cell cycle-modulating interventions. To
establish an in vitro and in vivo screening system for such
factors and substances, we crossed the aMHC-H2B-mCh
mice with mice expressing the CAG-eGFP-anillin trans-
gene [15], which visualizes cell cycle activity with high
resolution of M-phase. In this double transgenic mouse
line, CMs can be identified by nuclear expression of H2B-
mCh and their cell cycle status by localization of the eGFP-
anillin fusion protein (Fig. 8a). As proof of concept, we
used postnatal CMs derived from double transgenic mice to
test the influence of substances on cell cycle activity and
proliferative behavior in vitro. We chose P2 mice for the
experiment, as this age demarcates the time frame in which
CMs are still proliferative, but will soon undergo the
transition to binucleation, starting around P4. As the ex-
periment lasts 3 days, which corresponds to P3–P5, both
regular proliferation as well as cell cycle variations will
take place, thereby providing a challenge for the detection
system to correctly distinguish between the two states.
Ventricles from P2 mice were dissociated and the cells
were transfected with either microRNA 199, (miR-199)
which was reported to strongly enhance the rate of prolif-
eration in postnatal CMs [10] or scramble miRs as a
negative control. By counting eGFP-anillin expressing
CMs, which could be identified according to their H2B-
mCh fluorescence, increased cell cycle activity after
treatment with miR-199 compared to the scramble miR
control could be directly detected without further stainings
(Fig. 8b). While in transfections with scramble miRs, a
basal cell cycle activity (6.6 %) could be determined, this
was significantly (p = 0.0015) enhanced (19.1 %) after
transfection with miR-199 (Fig. 8c). Importantly, the
fraction of non-nuclear localizations of the eGFP-anillin
signal, such as contractile rings and midbodies (Fig. 8d),
which are indicative for cell division [15] and were verified
by staining for Aurora B kinase (Fig. 8e), was increased
after miR-199 treatment compared to the control (Fig. 8f).
Further we noticed an increase in the fraction of binucle-
ated CMs in miR-199-treated CMs (Fig. 8g). As the
strength of our system is live-tracking of cell cycle pro-
gression, we performed video microscopy, which revealed
both CMs’ divisions (Suppl. Video 2) as well as binucle-
ation (Suppl. Videos 3 ? 4) taking place. Binucleation was
determined as 17.7 % of total CMs for miR-199 treatment
and only 9.8 % for controls. This experiment demonstrates
that the aMHC-H2B-mCh/CAG-eGFP-anillin system not
only enables the identification of proliferation, but also of
cell cycle variations such as binucleation. Therefore, it is
ideally suited for screening of cell cycle-modifying sub-
stances in CMs.
bFig. 6 Determination of nuclearity and DNA content in H2B-mCh
CMs. a Portion of CMs with two nuclei in one section (n = 3, 2
z-stacks per heart) determined in thick slice 3D reconstruction and
virtual longitudinal and cross sections. b Quantification of the
percentage of binuclear CMs in LV left ventricle and RV right
ventricle at P3 (n C 3), P7 (n C 3), 9 W (n = 3), and in A atrium at
9 W (n = 2). Quantification was performed in z-stacks of thick slices
for 9 W and cell dissociation for P3, P7, and 9 W. c Single z-layers of
thick heart slices show differences in the tissue morphology of the LV
left ventricle and A atrium at adult stage. Membranes are stained with
Wheat germ agglutinin (green). Scale bar 50 lm. d Calculation of the
portion of CMs taking into account the numbers of Fig. 5b and the
grade of binuclearity from thick slices and cell dissociation.
e Relative DNA content of Langendorff isolated CMs as assessed
by H2B-mCh intensity or Hoechst intensity, respectively. f Represen-
tative flow cytometric analysis of the ploidy of H2B-mCh single adult
DAPI positive nuclei. g Representative flow cytometric analysis of
the fluorescence intensity of mCh from diploid and tetraploid CM
nuclei. h Representative flow cytometric analysis of the fluorescence
intensity of mCh? nuclei
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BE Hoechst autofluo H2B-mCh DIC
A autofluo H2B-mCh
Hoechst autofluo H2B-mCh DICF
Hoechst autofluo H2B-mCh
C Hoechst H2B-mCh α-actinin Hoechst H2B-mCh cTropTD
Fig. 7 Visualization of CM
nuclei after cardiac infarction.
a Macroscopic pictures of an
aMHC-H2B-mCh heart 10 days
after cryoinjury. Close-up
depicts border zone region.
Scale bars overview: 1 mm,
close-up: 200 lm. b Section of
a cryo-infarcted aMHC-H2B-
mCh heart. H2B-mCh signals
are only abundant in intact CMs
and are lost in the infarcted
region. Scale bar 200 lm. (c,
d) aMHC-H2B-mCh? heart
section stained with either a-
actinin (c) or cardiac Troponin
T (d) to identify CMs. Good co-
localization between the cardiac
markers and H2B-mCh in the
border zone. Scale bars 20 lm.
e H2B-mCh expression
facilitates the identification of
CM nuclei in cross sections of
the border zone. Arrows depict
CM nuclei, which are not
centered in the cell. Scale bar
20 lm. f H2B-mCh expression
facilitates the identification of
individual surviving CMs
(arrows) within the lesioned
area. Scale bar 20 lm
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Discussion
We have generated a novel transgenic model for the direct
visualization of CM nuclei in vitro and in vivo. This system
is based on the expression of a fusion protein consisting of
the human histone 2B and the red fluorescent protein mCh
under transcriptional control of the CM specific Myh6
promoter, resulting in a nuclear signal. We showed the
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Fig. 8 Assay for screening the effects of cell cycle modifying
substances on CMs. a Scheme depicts the cross-breeding of aMHC-
H2B-mCh mice with the CAG-eGFP-anillin proliferation indicator
mouse. Depending on the cell cycle status, CMs (H2B-mCh? nuclei)
express eGFP-anillin in different subcellular localizations. b Fluores-
cence pictures of dissociated aMHC-H2B-mCh/CAG-eGFP-anillin
double transgenic hearts (P2), transfected with the cell cycle-
modifying miR-199 and a miR-NC. Scale bars 100 lm. c Quantifi-
cation of eGFP-anillin expression in miR-treated CMs 72 h after
transfection (n C 3). d Examples of CMs with cytokinesis-indicating
eGFP-anillin localizations (arrows). Scale bars 100 lm. e Staining of
eGFP-anillin/H2B-mCh CMs with the proliferation marker AURKB
Aurora B kinase. Note the overlap between the M-phase specific
localization of eGFP-anillin (green) contractile ring and Aurora B
kinase (white). Scale bar 10 lm. f Analysis of different eGFP-anillin
localizations in CMs after miR-treatment (n C 3). g Portion of
binuclear CMs 72 h after miR-transfection (n C 3)
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As the mammalian heart consists of mono- and
binucleated CMs, it was of great interest to determine the
fraction and nuclearity of CMs in different regions of the
mouse heart. The contribution of CMs to total number of
heart cells in adult humans and rodents has been estimated
to be 15–20 % [37, 42]. However, for mice, even sub-
stantially higher estimates have been reported, assigning an
exceptional role for this species [2]. We can clearly ex-
clude this and confirm earlier estimates of\15 % CMs,
which correspond to\30 % CM nuclei [37, 43]. While
previous quantifications were based on cell suspensions of
dissociated hearts, our data are based on (1) flow cytometry
of isolated nuclei, (2) quantification on tissue sections, (3)
Langendorff isolation, as well as (4) 3D-reconstruction and
(5) Z-stack analysis of cardiac slices. Cell isolation pro-
cedures in general cannot guarantee uniform extraction of
all cell types. Cells that are more sensitive to enzymatic
treatment are prone to be damaged, while cells surrounded
by connective tissue are less likely to be dissolved from the
tissue. By using Z-stacks of cardiac sections for quantita-
tion, we found a significantly lower fraction of binuclear
CMs as with enzymatic dissociation. A recent study in
which histological sections were used also reported higher
numbers of mononuclear CMs (24 % [33]) that match our
observations of *25 %. In atria of adult mice, we found
an even higher fraction of mononucleated cells of *86 %.
The functional difference between mono- and binucleated
CMs is unknown. However, there is evidence that
mononucleated CMs are prone to enter the cell cycle after
stimulation with neuregulin [7] or after cardiac lesion [33].
Interestingly, atrial mononuclear CMs display cell cycle
activity after experimental lesion in the left ventricle in
rats, which was attributed to either cell division [32] or
increased binucleation [28].
Additionally, we also addressed the issue of CM frac-
tions in the context of cardiac growth and spatial distri-
bution in the heart, which is of relevance for studying
cardiac regeneration as it has been shown that neonate
mammalian hearts have a remarkable regenerative capacity
[30]. We found a significantly higher proportion of CMs at
P3 compared to P7 and adult mice which is most likely due
to the extensive proliferation of fibroblasts taking place
from P1 to P10 [37]. The spatial distribution of CMs re-
vealed only a difference in atria of P3, P7, and adult mice,
in which the fraction of CMs was significantly higher
compared to the ventricles. This is due to the significantly
lower fraction of binucleated cells in atria of mouse, which
was *14 % in adults.
A promising strategy for regeneration of lost CMs is the
re-induction of CM division by application of proliferation-
inducing substances. However to identify such factors and
to verify them in vivo, CM nuclei and cell division need to
be unequivocally identified.
The advantages of our CM proliferation assessment as-
say, which is based on H2B-mCh/eGFP-anillin compound
transgenic mice, are the immediate CM nuclei identifica-
tion and quantification of cell cycle activity due to the
fluorescent labels and in particular the possibility to live-
monitor cell cycle progression of CMs. In contrast, most
commonly used assays use BrdU and stainings with com-
binations of Ki-67, pHH3, PCNA, and AuroraB-kinase [7,
9, 10, 41] which require fixation and prevent the direct
follow-up of cell fate. As a proof of concept, we were able
to verify the proliferation-inducing effect of miR-199, as
previously published [10]. Due to the high resolution of
M-phase, the eGFP-anillin assay also allows us to dis-
criminate between cell division and cell cycle variations
such as endoreduplication and acytokinetic mitosis leading
to binucleation [15]. Surprisingly, treatment with miR-199
led to an increase of binucleated CMs, indicating induction
of cell cycle variations. In summary, the H2B-mCh/eGFP-
anillin assay will provide crucial information about the true
nature of cell cycle activity in the future.
Currently, identification of CMs is mostly based on
staining of the contractile apparatus (cTropI, cTropT or a-
actinin) or on the use of transgenic mouse models such as
aMHC-mCh mice [19] or aMHC-Cre inducible mice [34]
which provide CM-specific cytoplasmic expression of
fluorescence reporters [18]. As a caveat, these techniques
do not allow a direct correlation of nuclei to the marked
CMs. False positive identification of a non-CM nucleus as
cell cycle active CM nucleus may strongly alter a con-
clusion concerning the regeneration potential of adult CMs
as the numbers of CMs with cell cycle activity are de-
scribed to be very low (1 in 180,000) [36]. Indeed, a lack of
proper identification of CM nuclei seems to be one of the
major reasons for the high divergences in literature con-
cerning the annual turnover rate of adult mouse CMs,
ranging from 0.76 % [33] up to 80 % [17].
Currently only one further transgenic mouse model,
MHC-nLAC, has been described which enables a specific
identification of CM nuclei by staining for b-galactosidase
activity [38]. As a shortcoming, the nuclear signal is re-
placed by a diffuse cytoplasmic signal in CMs as soon as
the nuclear envelope dissolves. This complicates quantifi-
cations of CM nuclei if cells enter M-Phase. The H2B-mCh
mice described here have two advantages over the existing
mouse lines, which use NLS or cytoplasmic expression of a
CM specific marker: first, compared to lacZ as a marker
[38] no additional staining step is needed, which is par-
ticulary important for live-imaging applications and sec-
ond, due to the fusion to histone H2B, mCh stays
connected to the chromosomes during all phases of the cell
cycle, a prerequisite for automatic cell tracking in a
screening assay [27]. Furthermore, our mouse model can
also be used to directly and specifically isolate CM nuclei
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for the analysis of epigenetic chromatin modifications, an
approach recently established in CMs [13]. Taken together,
our transgenic system provides a new technology for the
identification of CM nuclei without any further treatment
and for the isolation of CM nuclei for downstream appli-
cations. In combination with the eGFP-anillin system, it is
a novel tool to specifically resolve controversial questions
in the cardiac field, such as the ongoing debate, if adult
CMs have the potential to divide. This mouse line will be
useful for assessing proliferation in models of cardiac re-
generation, for the differentiation between atrial and ven-
tricular CMs during embryonic development, identification
of CMs in screening assays for proliferation-inducing
substances, transplantation experiments, and for the ana-
lysis of plasticity of adult CMs in future studies.
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